Neuraceq
Active substance: florbetaben f-18
INJECTION, SOLUTION · FLORBETABEN F-18 135 mCi/mL
United StatesActive
Marketing holder: Lantheus Biosciences Ltd., a Lantheus company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FLORBETABEN F-18 · 135 mCi/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-743b-7964-a907-2a401d6dd05c;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 54828-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 54828-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 54828-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 54828-001 · Verified 2026-10-09 · open in source